MTVA
Price
$1.66
Change
-$0.09 (-5.14%)
Updated
Sep 11 closing price
Capitalization
10.94M
65 days until earnings call
Intraday BUY SELL Signals
PMVP
Price
$1.40
Change
-$0.04 (-2.78%)
Updated
Sep 11 closing price
Capitalization
75.91M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MTVA vs PMVP

MTVA vs PMVP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MTVA vs. PMVP commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTVA is a Hold and PMVP is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PMVP($75.9M) has a higher market cap than MTVA($10.9M). PMVP YTD gains are higher at: 12.000 vs. MTVA (-80.285). MTVA has higher annual earnings (EBITDA): -14.91M vs. PMVP (-79.54M). PMVP has more cash in the bank: 79.4M vs. MTVA (12.6M). MTVA has less debt than PMVP: MTVA (177K) vs PMVP (217K). MTVA (0) and PMVP (0) have equivalent revenues.
MTVAPMVPMTVA / PMVP
Capitalization10.9M75.9M14%
EBITDA-14.91M-79.54M19%
Gain YTD-80.28512.000-669%
P/E RatioN/AN/A-
Revenue00-
Total Cash12.6M79.4M16%
Total Debt177K217K82%
FUNDAMENTALS RATINGS
MTVA vs PMVP: Fundamental Ratings
MTVA
PMVP
OUTLOOK RATING
1..100
4393
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
5042
P/E GROWTH RATING
1..100
10080
SEASONALITY SCORE
1..100
1585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTVA's Valuation (17) in the null industry is somewhat better than the same rating for PMVP (56). This means that MTVA’s stock grew somewhat faster than PMVP’s over the last 12 months.

MTVA's Profit vs Risk Rating (100) in the null industry is in the same range as PMVP (100). This means that MTVA’s stock grew similarly to PMVP’s over the last 12 months.

PMVP's SMR Rating (98) in the null industry is in the same range as MTVA (99). This means that PMVP’s stock grew similarly to MTVA’s over the last 12 months.

PMVP's Price Growth Rating (42) in the null industry is in the same range as MTVA (50). This means that PMVP’s stock grew similarly to MTVA’s over the last 12 months.

PMVP's P/E Growth Rating (80) in the null industry is in the same range as MTVA (100). This means that PMVP’s stock grew similarly to MTVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MTVAPMVP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (MTVA: $1.66 vs. PMVP: $1.40)
Brand notoriety: MTVA and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MTVA: 19% vs. PMVP: 115%
Market capitalization -- MTVA: $10.94M vs. PMVP: $75.91M
MTVA [@Biotechnology] is valued at $10.94M. PMVP’s [@Biotechnology] market capitalization is $75.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTVA’s FA Score shows that 1 FA rating(s) are green while PMVP’s FA Score has 0 green FA rating(s).

  • MTVA’s FA Score: 1 green, 4 red.
  • PMVP’s FA Score: 0 green, 5 red.
According to our system of comparison, MTVA is a better buy in the long-term than PMVP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTVA’s TA Score shows that 6 TA indicator(s) are bullish while PMVP’s TA Score has 6 bullish TA indicator(s).

  • MTVA’s TA Score: 6 bullish, 4 bearish.
  • PMVP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both MTVA and PMVP are a good buy in the short-term.

Price Growth

MTVA (@Biotechnology) experienced а -5.14% price change this week, while PMVP (@Biotechnology) price change was +8.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

MTVA is expected to report earnings on Nov 16, 2026.

PMVP is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
MTVA
Daily Signal:
Gain/Loss:
PMVP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCAYX12.69N/A
N/A
Invesco Income Advantage U.S. Fund Y
MSERX9.02N/A
N/A
MassMutual Small Cap Growth Eq R4
EEQAX11.15N/A
N/A
BTS Enhanced Equity Income A
EZTGX61.12N/A
N/A
Eaton Vance Tx-Mgd Growth 1.2 C
LAFTX22.48N/A
N/A
Lord Abbett Affiliated R5

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-2.78%
CLLS - PMVP
39%
Loosely correlated
+1.64%
MTVA - PMVP
35%
Loosely correlated
-5.14%
AXON - PMVP
31%
Poorly correlated
+0.10%
ARRY - PMVP
31%
Poorly correlated
+1.54%
VCYT - PMVP
30%
Poorly correlated
-2.76%
More